Elyse Shuk
Overview
Explore the profile of Elyse Shuk including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
600
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Saracino R, Park E, Shuk E, Rosenfeld B, Roth A, Nelson C
Clin Gerontol
. 2024 Jul;
:1-11.
PMID: 38961750
Objectives: The objective of this study was to engage national experts in geriatric psychiatry and oncology in qualitative interviews to develop consensus regarding how older adult cancer survivors (OACS) experience...
2.
Saracino R, Tobias K, Shuk E, Avildsen I, Emanu J, Demirjian C, et al.
Aging Ment Health
. 2023 Mar;
27(9):1744-1751.
PMID: 36907588
Objective: To identify the phenomenology of depression in older adults with cancer (OACs) in order to improve the accuracy of depression screening for this population. Method: Inclusion criteria were: ≥70 ...
3.
Jenkelowitz J, Garzon M, Lynch K, Shuk E, Feindler E, Landau H, et al.
Palliat Support Care
. 2020 Oct;
19(4):397-404.
PMID: 33118909
Objective: Home care for hematopoietic stem cell transplants (HSCTs), an alternative to traditional inpatient or outpatient recovery programs, is safe and feasible but may place greater demand on full-time caregivers....
4.
Hamilton J, Garzon M, Shah I, Cadet K, Shuk E, Westerman J, et al.
Public Health Genomics
. 2020 Mar;
23(1-2):6-19.
PMID: 32191943
Introduction: Genetic risk modifier testing (GRMT), an emerging form of genetic testing based on common single nucleotide polymorphisms and polygenic risk scores, has the potential to refine estimates of BRCA1/2...
5.
Hamilton J, Shuk E, Garzon M, Rodriguez V, Westerman J, Hay J, et al.
JCO Precis Oncol
. 2020 Jan;
1.
PMID: 31938761
Purpose: In patients with advanced cancers, tumor genomic profiling (TGP) can reveal secondary germline findings (SGFs) regarding inherited disease risks. This study examines the process by which patients with advanced...
6.
Holland S, Shuk E, Burkhalter J, Shouery M, Li Y, Hay J
Psychooncology
. 2019 Sep;
29(1):156-163.
PMID: 31520426
Objective: We developed an interactive voice response system (IVRS), an automated telephone survey technology, to assess real-time decision making about sun protection. We examined the feasibility and acceptability of IVRS...
7.
Cowan R, Shuk E, Byrne M, Abu-Rustum N, Chi D, Boutin-Foster C, et al.
J Oncol Pract
. 2019 Jul;
15(9):e769-e776.
PMID: 31335249
Objective: Disparities exist between population subgroups in the use of gynecologic oncologists and high-volume hospitals. The objectives of this study were to explore the experiences of black women obtaining ovarian...
8.
Epstein A, Hamilton J, Shuk E, Romano D, Lynch K, Khan E, et al.
J Pain Symptom Manage
. 2019 Jul;
58(5):792-804.e6.
PMID: 31302259
Context: Research Medical Donation (RMD), which entails collecting human tissue within hours after death, benefits cancer research but data are limited regarding barriers institutions face accruing patients to RMD programs....
9.
Agarwal R, Shuk E, Romano D, Genoff M, Li Y, OReilly E, et al.
Support Care Cancer
. 2019 Jun;
28(3):1109-1119.
PMID: 31197540
Purpose: Person-Centered Oncologic Care and Choices (P-COCC) combines an advance care planning (ACP) value-focused patient interview with a care goal video decision aid. Our randomized study showed that P-COCC was...
10.
Diamond E, Reiner A, Buthorn J, Shuk E, Applebaum A, Hyman D, et al.
Blood Adv
. 2019 Mar;
3(7):934-938.
PMID: 30917949
Erdheim-Chester disease (ECD) is an ultra-rare hematologic neoplasm characterized by somatic mutations of the MAPK pathway and by accumulation of lesional histiocytes within tissues. Clinical phenotypes and sites of disease...